Literature DB >> 7951930

Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy.

R D Yee1, A K Selky, V A Purvin.   

Abstract

Efficacy of optic nerve sheath decompression (ONSD) in treating non-arteritic ischemic optic neuropathy (NAION) is not clear. We retrospectively analyzed the records of 91 patients with NAION, who were examined during a two-year period, and compared the final Snellen visual acuities of eyes treated with ONSD with those of eyes that did not have surgery. Seven of 18 eyes with ONSD (39%) demonstrated increased visual acuity of two or more lines; whereas 23 of 71 eyes without surgery (32%) had increased acuity. The ONSD group and no surgery group were further subdivided into eyes with progressive visual loss and nonprogressive visual loss. No statistically significant differences in visual outcome between groups were found. We did not find the high frequency of visual improvement that has been reported in some studies of ONSD for NAION.

Entities:  

Mesh:

Year:  1994        PMID: 7951930

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  5 in total

1.  Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy.

Authors:  C Yu; J K Ho; Y J Liao
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

Review 2.  Surgery for nonarteritic anterior ischemic optic neuropathy.

Authors:  Kay Dickersin; Eric Manheimer; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

Review 3.  Surgery for nonarteritic anterior ischemic optic neuropathy.

Authors:  Kay Dickersin; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2015-03-12

4.  Sequential development of non-arteritic anterior ischemic optic neuropathy in a patient on hemodialysis.

Authors:  Mukesh Jain; Renuka Srinivasan; K Ramesh Babu; M Swapnil Parchand
Journal:  GMS Ophthalmol Cases       Date:  2017-09-01

5.  Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait.

Authors:  Raed Behbehani; Abdullah Ali; Ashref Al-Moosa
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.